Ipratropium bromide is an anticholinergic bronchodilator; combined with albuterol it is used for acute and maintenance treatment of asthma/COPD. Atrovent HFA: 17 mcg/dose (200 actuations). Nebulized solution: 0.02% (500 mcg/2.5 mL). Nasal spray: 0.03% (21 mcg/spray), 0.06% (42 mcg/spray). Combination: nebulized 0.5 mg ipratropium + 2.5 mg albuterol per 3…
Common clinical indications
Acute asthma exacerbation (ED/ICU)—ipratropium alone or with albuterol
Ipratropium Bromide ± Albuterol (Ipratropium Bromide) is listed in YMed Atlas under Bronchodilator. Indications, dosing, and safety information on this page summarize curated references—always confirm with current labeling, formularies, and local protocols.
How do I adjust dosing for renal impairment or special populations?
Review the dosing sections and references for this monograph. Many agents require renal or hepatic adjustment; pediatric, pregnancy, and lactation considerations are clinician-specific. This interface is educational and does not replace individualized prescribing decisions.
Is this medical advice?
No. YMed Atlas drug pages support learning and quick reference. They are not a substitute for clinical judgment, pharmacist review, or formal interaction checking with a complete medication list.
